0

0

0

0

0

0

0

0

0

healthcare | IST

India approves two COVID-19 vaccines; experts discuss the way forward

Mini

India’s wait for the COVID-19 vaccine seems to be over. Exactly 11 months and three days after India reported its first case of coronavirus, India’s drug regulator has approved two vaccines for the disease which has claimed around 1.5 lakh lives so far across the country. Adar Poonawalla, CEO of Serum Institute of India, Kiran Mazumdar-Shaw, Executive Chairperson of Biocon, Dr Randeep Guleria, Director at AIIMS and Dr Gagandeep Kang, Professor at Christian Medical College discussed the same in an interview with CNBC-TV18.

India’s wait for the COVID-19 vaccine seems to be over. Exactly 11 months and three days after India reported its first case of coronavirus, India’s drug regulator has approved two vaccines for the disease which has claimed around 1.5 lakh lives so far across the country.
The first vaccine, which has received the restricted emergency use approval is Covishield. This is the vaccine that has been developed by Oxford and Astrazeneca and is being manufactured in India by the world’s largest vaccine manufacturer the Serum Institute of India.
The second vaccine to get the greenlight is Covaxin, being developed by Hyderabad based Bharat Biotech in partnership with the Indian Council of Medical Research (ICMR) and the National Institute of Virology in Pune.
Adar Poonawalla, CEO of Serum Institute of India, Kiran Mazumdar-Shaw, Executive Chairperson of Biocon, Dr Randeep Guleria, Director at AIIMS and Dr Gagandeep Kang, Professor at Christian Medical College discussed the same in an interview with CNBC-TV18.
Watch the view for the full interview.